Kmt2a cooperates with menin to suppress tumorigenesis in mouse pancreatic islets.

about

The future: genetics advances in MEN1 therapeutic approaches and management strategies.

P2860

Q47814736-51E605C9-C2C3-4AEC-B732-1D4AC049C401

P2860

Kmt2a cooperates with menin to suppress tumorigenesis in mouse pancreatic islets.

Item

http://www.wikidata.org/entity/Q37544748

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Kmt2a cooperates with menin to suppress tumorigenesis in mouse pancreatic islets.

@en

Kmt2a cooperates with menin to suppress tumorigenesis in mouse pancreatic islets.

@nl

type

Item

label

Kmt2a cooperates with menin to suppress tumorigenesis in mouse pancreatic islets.

@en

Kmt2a cooperates with menin to suppress tumorigenesis in mouse pancreatic islets.

@nl

prefLabel

Kmt2a cooperates with menin to suppress tumorigenesis in mouse pancreatic islets.

@en

Kmt2a cooperates with menin to suppress tumorigenesis in mouse pancreatic islets.

@nl

P1476

Kmt2a cooperates with menin to suppress tumorigenesis in mouse pancreatic islets.

@en

P2093

Hong Li

http://www.w3.org/2001/XMLSchema#string

Joshua M Francis

http://www.w3.org/2001/XMLSchema#string

Wenchu Lin

http://www.w3.org/2001/XMLSchema#string

Xiaoping Gao

http://www.w3.org/2001/XMLSchema#string

P2860

Structure-based design of high-affinity macrocyclic peptidomimetics to block the menin-mixed lineage leukemia 1 (MLL1) protein-protein interaction

DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors

Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation

Altered Hox expression and segmental identity in Mll-mutant mice

Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia

Sunitinib malate for the treatment of pancreatic neuroendocrine tumors.

Everolimus for advanced pancreatic neuroendocrine tumors.

Loss of the retinoblastoma binding protein 2 (RBP2) histone demethylase suppresses tumorigenesis in mice lacking Rb1 or Men1

Pharmacologic inhibition of the Menin-MLL interaction blocks progression of MLL leukemia in vivo.

Multicenter Phase II Trial of Temsirolimus and Bevacizumab in Pancreatic Neuroendocrine Tumors.

P304

1274-1281

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/15384047.2016.1250986

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Chandra Sekhar Pedamallu

Matthew Meyerson

P Ernst

P577

2016-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27801610

http://www.w3.org/2001/XMLSchema#string

P932

5199165

http://www.w3.org/2001/XMLSchema#string

Kmt2a cooperates with menin to suppress tumorigenesis in mouse pancreatic islets.

about

P2860

P2860

Kmt2a cooperates with menin to suppress tumorigenesis in mouse pancreatic islets.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932